Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schellhammer

Showing results (261-270 of 326) with videos related to

Pageof 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometryLisa H Cazares, Bao-Ling Adam, Michael D Ward, et al.
Cancer Research|November 1, 1983
Immunohistochemical localization of prostate carcinoma-associated antigensG L Wright, M L Beckett, J J Starling, et al.
European Journal of Radiology|April 11, 2009
Fibromuscular dysplasia in living renal donors: still a challenge to computed tomographic angiographyD Blondin, R Lanzman, F Schellhammer, et al.
Clinical Chemistry|June 11, 1992
Two-site monoclonal antibody-based immunoradiometric assay for measuring prostate secretory protein in serumC L Huang, H M Liang, D Brassil, et al.
Urology|July 11, 2009
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancerOliver Sartor, David G McLeod, Susan Halabi, et al.
Cancer|June 19, 2009
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancerCelestia S Higano, Paul F Schellhammer, Eric J Small, et al.
Cancer Genetics and Cytogenetics|August 1, 1991
Cytogenetic evaluation of 20 cultured primary prostatic tumorsA R Brothman, D M Peehl, A M Patel, et al.
Cancer Research|April 29, 2000
Flt3-ligand induces transient tumor regression in an ectopic treatment model of major histocompatibility complex-negative prostate cancerR P Ciavarra, K D Somers, R R Brown, et al.
Urologic Oncology|March 8, 2006
Overexpression of alpha-defensin is associated with bladder cancer invasivenessDaniel A Holterman, Jose I Diaz, Peter F Blackmore, et al.
Journal of Endourology|November 11, 2006
Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institutionAdam J Ball, Bethany Gambill, Michael D Fabrizio, et al.
Pageof 33

Showing results (261-270 of 326) with videos related to

Sort By:
Pageof 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometryLisa H Cazares, Bao-Ling Adam, Michael D Ward, et al.
Cancer Research|November 1, 1983
Immunohistochemical localization of prostate carcinoma-associated antigensG L Wright, M L Beckett, J J Starling, et al.
European Journal of Radiology|April 11, 2009
Fibromuscular dysplasia in living renal donors: still a challenge to computed tomographic angiographyD Blondin, R Lanzman, F Schellhammer, et al.
Clinical Chemistry|June 11, 1992
Two-site monoclonal antibody-based immunoradiometric assay for measuring prostate secretory protein in serumC L Huang, H M Liang, D Brassil, et al.
Urology|July 11, 2009
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancerOliver Sartor, David G McLeod, Susan Halabi, et al.
Cancer|June 19, 2009
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancerCelestia S Higano, Paul F Schellhammer, Eric J Small, et al.
Cancer Genetics and Cytogenetics|August 1, 1991
Cytogenetic evaluation of 20 cultured primary prostatic tumorsA R Brothman, D M Peehl, A M Patel, et al.
Cancer Research|April 29, 2000
Flt3-ligand induces transient tumor regression in an ectopic treatment model of major histocompatibility complex-negative prostate cancerR P Ciavarra, K D Somers, R R Brown, et al.
Urologic Oncology|March 8, 2006
Overexpression of alpha-defensin is associated with bladder cancer invasivenessDaniel A Holterman, Jose I Diaz, Peter F Blackmore, et al.
Journal of Endourology|November 11, 2006
Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institutionAdam J Ball, Bethany Gambill, Michael D Fabrizio, et al.
Pageof 33